文献速递慢性肾脏病肾血管病与高血压

全球肾脏病患者24小时血压谱差异:I-DARE研究

Variations in 24-Hour BP Profiles in Cohorts of Patients with Kidney Disease around the World: The I-DARE Study.
PubMed 文献 · Clin J Am Soc Nephrol · 2018-07-05

I-DARE研究汇总意大利、西班牙、美国CRIC与AASK及日本CKD-JAC共7518例CKD患者的动态血压数据,比较白大衣与隐匿性高血压患病率差异。结果显示,在诊室血压达标者中,AASK隐匿性高血压患病率高于CKD-JAC,而CRIC、意大利和西班牙队列较低;在诊室血压升高者中,AASK持续性高血压患病率较高,意大利和西班牙较低。

要点

  • CKD患者隐匿性和持续性高血压患病率在不同国家队列间存在独立于重要合并症的差异
  • 男性、糖尿病、使用≥4种降压药及中重度蛋白尿者隐匿性和持续性高血压患病率更高
  • 诊室血压达标不能排除24小时动态血压未控制,需关注隐匿性高血压

核心结论

  • 在大型多国数据库中,隐匿性和持续性高血压患病率在不同CKD队列间存在差异,且独立于重要合并症。

研究设计与样本

  • 国际多中心协作组建立CKD患者人口学、临床和动态血压数据库,纳入意大利、西班牙、美国CRIC和AASK及日本CKD-JAC队列共7518例CKD患者。

主要发现

  • 诊室血压达标者中,与CKD-JAC相比,AASK隐匿性高血压患病率比为1.21(95%CI 1.04–1.41),CRIC为0.82(0.72–0.94),意大利为0.73(0.56–0.95),西班牙为0.75(0.64–0.88)。
  • 诊室血压升高者中,与CKD-JAC相比,AASK持续性高血压患病率比为1.22(95%CI 1.13–1.32),意大利为0.78(0.70–0.87),西班牙为0.89(0.82–0.96),CRIC与CKD-JAC相似。
  • 男性、糖尿病、使用四种或以上降压药及中重度蛋白尿者隐匿性和持续性高血压患病率升高。

关键数值与推荐

  • 诊室血压控制切点为140/90 mm Hg,24小时动态血压控制切点为130/80 mm Hg。

临床怎么用

  • CKD患者即使诊室血压达标,也应考虑24小时动态血压监测以识别隐匿性高血压,尤其男性、糖尿病、多药降压及中重度蛋白尿者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Ambulatory BP is increasingly recognized as a better measure of the risk for adverse outcomes related to hypertension, an important comorbidity in patients with CKD. Varying definitions of white-coat and masked hypertension have made it difficult to evaluate differences in prevalence of these BP patterns across CKD cohorts. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The International Database of Ambulatory BP in Renal Patients collaborative group established a large database of demographic, clinical, and ambulatory BP data from patients with CKD from cohorts in Italy, Spain, the Chronic Renal Insufficiency Cohort (CRIC) and the African American Study of Kidney Disease and Hypertension Cohort Study (AASK) in the United States, and the CKD Japan Cohort (CKD-JAC). Participants (n=7518) with CKD were included in the present analyses. Cutoffs for defining controlled BP were 140/90 mm Hg for clinic and 130/80 mm Hg for 24-hour ambulatory BP. RESULTS: Among those with controlled clinic BP, compared with CKD-JAC, AASK participants were more likely to have masked hypertension (prevalence ratio [PR], 1.21; 95% confidence interval [95% CI], 1.04 to 1.41) whereas CRIC (PR, 0.82; 0.72 to 0.94), Italian (PR, 0.73; 0.56 to 0.95), and Spanish participants (PR, 0.75; 0.64 to 0.88) were less likely. Among those with elevated clinic BP, AASK participants were more likely to have sustained hypertension (PR, 1.22; 95% CI, 1.13 to 1.32) whereas Italian (PR, 0.78; 0.70 to 0.87) and Spanish participants (PR, 0.89; 0.82 to 0.96) were less likely, although CRIC participants had similar prevalence as CKD-JAC. Prevalence of masked and sustained hypertension was elevated in males, patients with diabetes, participants on four or more antihypertensives, and those with moderate-to-severe proteinuria. CONCLUSIONS: In a large, multinational database, the prevalence of masked and sustained hypertension varied across cohorts independent of important comorbidities.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Drawz PE, Brown R, De Nicola L, et al. Variations in 24-Hour BP Profiles in Cohorts of Patients with Kidney Disease around the World: The I-DARE Study. Clin J Am Soc Nephrol. 2018. PMID: 29976600. doi:10.2215/CJN.13181117

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。